Agere Pharmaceuticals

Agere Pharmaceuticals Overview

Founded 2008
Status Acquired/​Merged
Employees 53
Latest Deal Type M&A
Financing Rounds 1

Agere Pharmaceuticals General Information


Operator of a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. The company specializes in improving the oral bioavailability of BCS II - IV compounds through fundamental science, solubilization expertise, and proprietary solubilization technologies.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Primary Office
  • 62925 NorthEast 18th Street
  • Bend, OR 97701
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Agere Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Agere Pharmaceuticals‘s full profile, request access.

Request a free trial

Agere Pharmaceuticals Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Ziopharm Oncology Corporation Boston, MA 00 00000 00000000000 00000
000000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000

Agere Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Marshall Crew Ph.D President & Chief Executive Officer
Casey Jones Vice President, Corporate Development
Michael Deperro Vice President, Operations